#VisualAbstract: Once-weekly cisplatin is noninferior to cisplatin every 3 weeks for postoperative head and neck cancers

byTeddy Guo

August 3, 2022

in StudyGraphics

Reading Time: 1 min read

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

RelatedReports

StudyGraphics

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

October 25, 2022

StudyGraphics

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

October 19, 2022

StudyGraphics

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

October 18, 2022

#VisualAbstract: Adjuvant ibandronate does not improve survival in postmenopausal patients with ER⁺ breast cancer

StudyGraphics

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

October 5, 2022

Magnetic resonance cholangiopancreatography diagnoses bile duct obstruction with high sensitivity and specificity [Classics Series]

2 Minute Medicine Rewind January 28, 2019

Methotrexate reduces functional burden of disease in patients with arthralgia at-risk of developing rheumatoid arthritis

Rivaroxaban after TAVR linked with increased risk of adverse events compared to antiplatelet therapy

Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-Year clinical outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Once-weekly cisplatin is noninferior to cisplatin every 3 weeks for postoperative head and neck cancers

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

Magnetic resonance cholangiopancreatography diagnoses bile duct obstruction with high sensitivity and specificity [Classics Series]

RelatedReports

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

Magnetic resonance cholangiopancreatography diagnoses bile duct obstruction with high sensitivity and specificity [Classics Series]

Methotrexate reduces functional burden of disease in patients with arthralgia at-risk of developing rheumatoid arthritis

Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-Year clinical outcomes

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Once-weekly cisplatin is noninferior to cisplatin every 3 weeks for postoperative head and neck cancers

RELATED REPORTS

Breast ultrasound sensitive for cancer and carries a low false positive rate [Classics Series]

Magnetic resonance cholangiopancreatography diagnoses bile duct obstruction with high sensitivity and specificity [Classics Series]

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?